Masanori Tokumoto

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa
Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PloS one 17 (12) (2022)